Following an anonymous tip alleging improper pesticide testing procedures at Rapid Analytics, a cannabis testing lab in Natchez, Mississippi, the Mississippi State Department of Health (MSDH) has placed an administrative hold on all medical cannabis products tested at the facility. Lab spokesperson Mamie Henry emphasized that the hold threatens the survival of dispensaries, as Rapid Analytics conducts approximately 70 percent of the state’s cannabis testing.
“They have no basis for anything, except an anonymous call, which has effectively shut down the entire industry,” Henry stated in an interview. Dispensaries are currently unable to sell any cannabis products tested by Rapid Analytics until further notice from MSDH.
Impact on Dispensaries
Dispensaries have been informed by the Mississippi Medical Cannabis Program regarding which products are affected during the hold and subsequent retesting. A recent statement clarified that no dispensaries have been instructed to shut down and that not all products are on hold.
On Wednesday morning, MSDH notified Rapid Analytics of the complaint, prompting an emergency Zoom meeting to review the lab’s testing protocols and reports over the preceding months. While Mississippi has two medical cannabis testing labs—Rapid Analytics and Steep Hill Mississippi in Jackson—all products tested by Steep Hill remain deemed safe for patient consumption.
Cannabis cultivators must submit their products for testing to at least one of the labs before they can sell to dispensaries, with some opting for dual testing, such as 74 Suns in Canton. Consultant Hardy Case assured that 74 Suns’ medical cannabis is still available for sale since it passed inspection at Steep Hill.
Challenges Faced
“Many dispensaries currently have products that were previously tested and approved, but due to the administrative hold, they are unable to sell them,” Case noted. “It’s unfortunate that this situation is unfolding during a busy time of year.” Henry assured stakeholders that Rapid Analytics is responding swiftly and professionally to resolve the situation and expedite the reopening of the state market.
Concerns are mounting as the administrative hold coincides with the holiday season. Case mentioned that patients may face difficulties finding products in rural areas where dispensaries are few and far between.
Long-Term Consequences
Some cultivators and dispensaries fear lasting repercussions from the product hold. Case highlighted a local dispensary’s lack of available product, suggesting that some businesses might face permanent closure due to lost sales during this critical period.
This situation underscores the complexities of entering the Mississippi medical cannabis market, where businesses have already navigated numerous regulatory challenges. The Mississippi Medical Cannabis Program has initiated swift actions to address the hold in order to protect patient access to necessary medicinal products.
To stay informed about this evolving situation, stakeholders are encouraged to monitor official communications from the Mississippi Medical Cannabis Program and other authoritative sources.
